Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells

Endocrinology

Volumn 144, Issue 1, 2003, Pages 121-128

  Singleton, David W ^a   Feng, Yuxin ^a   Burd, Craig J ^a   Khan, Sohaib A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DNA; ESTROGEN RECEPTOR; FULVESTRANT; LIGAND; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; RALOXIFENE; THYMIDINE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; DNA TRANSCRIPTION; DRUG EFFECT; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; REPORTER GENE;

ADENOCARCINOMA; DNA; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HUMANS; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; RALOXIFENE; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037229883     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220625     Document Type: Article

References (42)

1. Watson CS, Norfleet AM, Pappas TC, Gametchu B 1999 Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α. Steroids 64:5-13
2. Pappas T, Gametchu B, Yannariello-Brown J, Collins TJ, Watson C 1994 Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2:813-822
3. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
4. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A 1995 Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214:847-855
5. Panickar KS, Purushotham K, King MA, Rajakumar G, Simpkins JW 1998 Hypoglycemia-induced seizures reduce cyclic AMP response element binding protein levels in the rat hippocampus. Neuroscience 83:1155-1160
6. Gridley KE, Green PS, Simpkins JW 1998 A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol 54:874-880
7. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M 2000 The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA 97:3602-3607
8. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM 1999 The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463
9. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
10. Razandi M, Pedram A, Levin ER 2000 Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14:1434-1447
11. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A, Auricchio F 1999 Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 18:2500-2510
12. Collins P, Webb C 1999 Estrogen hits the surface. Nat Med 5:1130-1131
13. Levin ER 1999 Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 10:374-377
14. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C 2000 Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J Biol Chem 275:18447-18453
15. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ 2002 Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 16:116-127
16. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
17. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP 1999 Caveolin-1 potentiates estrogen receptor α (ERα) signaling, caveolin-1 drives ligand-independent nuclear translocation and activation of ERα. J Biol Chem 274:33551-33556
18. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104:719-730
19. Shepard SB, Cooper AG 2000 Assessing the expression of two genes simultaneously in surgical specimens using polymerase chain reaction. Mod Pathol 13:401-406
20. Nishida M, Kasahara K, Oki A, Satoh T, Arai Y, Kubo T 1996 Establishment of eighteen clones of Ishikawa cells. Hum Cell 9:109-116
21. Nephew KP, Peters GA, Khan SA 1995 Cellular localization of estradiol-induced c-fos messenger ribonucleic acid in the rat uterus: c-fos Expression and uterine cell proliferation do not correlate strictly. Endocrinology 136:3007-3015
22. Nephew KP, Polek TC, Khan SA 1996 Tamoxifen-induced proto-oncogene expression persists in uterine endometrial epithelium. Endocrinology 137: 219-224
23. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
24. Joel PB, Traish AM, Lannigan DA 1995 Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052
25. Castano E, Chen CW, Vorojeikina DP, Notides AC 1998 The role of phosphorylation in human estrogen receptor function. J Steroid Biochem Mol Biol 65:101-110
26. Bhat KP, Pezzuto JM 2001 Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 61:6137-6144
27. Hall JM, McDonnell DP 1999 The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERa transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578
28. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM 2001 Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14:280-294
29. Bryant HU 2001 Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation. Rev Endocr Metab Disord 2:129-138
30. Vasudevan N, Kow LM, Pfaff DW 2001 Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc Natl Acad Sci USA 98:12267-12271
31. Karin M 1994 Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol 6:415-424
32. Treisman R 1995 Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 14:4905-4913
33. Duan R, Xie W, Burghardt RC, Safe S 2001 Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276:11590-11598
34. Seeman E 2001 Raloxifene. J Bone Miner Metab 19:65-75
35. Sexton MJ, Gherman RB 2001 Selective estrogen receptor modulators: The ideal estrogen replacement? Prim Care Update Oh Gyns 8:25-30
36. Al-Jamal JH, Dubin NH 2000 The effect of raloxifene on the uterine weight response in immature mice exposed to 17β-estradiol, 1,1,1-trichloro-2, 2-bis(p-chlorophenyl)ethane, and methoxychlor. Am J Obstet Gynecol 182:1099-1102
37. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S 2000 Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60:321-327
38. Harms C, Lautenschlager M, Bergk A, Katchanov J, Freyer D, Kapinya K, Herwig U, Megow D, Dirnagl U, Weber JR, Hortnagl H 2001 Differential mechanisms of neuroprotection by 17β-estradiol in apoptotic versus necrotic neurodegeneration. J Neurosci 21:2600-2609
39. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW 2000 Estrogen receptor a and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44-E52
40. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, Bilfinger TV 2000 Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101:1594-1597
41. Donahue JE, Stopa EG, Chorsky RL, King JC, Schipper HM, Tobet SA, Blaustein JD, Reichlin S 2000 Cells containing immunoreactive estrogen receptor-α in the human basal forebrain. Brain Res 856:142-151
42. Norfleet AM, Thomas ML, Gametchu B, Watson CS 1999 Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814